A Study to Evaluate AMG 133 Administered Subcutaneously in Participants With Overweight or Obesity

Summary

The primary objective of this study is to assess the pharmacokinetics (PK) of AMG 133 after multiple subcutaneous (SC) administrations in participants with overweight or obesity using various dose regimens.

Timeline

Start

2024-08-20

Primary completion

2024-12-27

Completion

2024-12-27

Drugs

Indications